Skip to main content

Anthracycline-DNA Complexes as Slow-Release Preparations in the Treatment of Acute Leukemia

  • Chapter

Abstract

The anthracycline antibiotics daunorubicin (DNR) and doxorubicin (DOX, adriamycin) play a prominent role in the treatment of acute leukemia.1,2 The most successful programs for treatment of acute non-lymphoblastic leukemia (ANLL) in adults now cause remission in about 70–80% of previously untreated patients. But most patients relapse despite maintenance therapy given at certain intervals. The response rate is then much lower and most of these patients are resistant to the drugs which initially caused remission.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M. Weil, O.J. Glidewell, C. Jacquillat, R. Levy, A.A. Serpick, P.N. Wiernik, J. Cuttner, B. Hoogstraten, L. Wasserman, R.R. Ellison, S. Gailani, K. Brunner, R.T. Silver, V.B. Rege, M.R. Cooper, L. Lowenstein, N.I. Nissen, F. Hauarni, J. Blom, M. Boiron, J. Bernard, and J.F. Holland, Cancer Res. 33: 921 (1973).

    PubMed  CAS  Google Scholar 

  2. S.K. Carter, Cancer Chemother. Rep. 6: 389 (1975).

    Google Scholar 

  3. C. Peterson and A. Trouet, Cancer Res. 38: 4645 (1978).

    PubMed  CAS  Google Scholar 

  4. W.J. Pigram, W. Fuller, and L.D. Hamilton, Nature New Biol. 235: 17 (1972).

    Article  PubMed  CAS  Google Scholar 

  5. Y.-J. Schneider, R. Baurain, A. Zenebergh, and A. Trouet, Cancer Chemother. Pharmacol. 2: 7 (1979).

    CAS  Google Scholar 

  6. G. Nöel, C. Peterson, A. Trouet, and P. Tulkens, Eur. J. Cancer 17: 363 (1978).

    Google Scholar 

  7. L. Lenaz and J.A. Page, Cancer Treat. Rev. 3: 111 (1976).

    Article  PubMed  CAS  Google Scholar 

  8. D.D. von Hoff, M. Rozencweig, M. Layard, M. Slavik, and F.M. Muggia, Am. J. Med. 63: 200 (1977).

    Article  Google Scholar 

  9. C. Praga, G. Beretta, P.L. Vigo, G.R. Lenaz, C. Pollini, G. Bonadonna, R. Canetta, R. Cavtellani, E. Villa, C.G. Gallagher, H. von Melchner, M. Hayat, P. Ribaud, G. De Wasch, W. Mattsson, R. Heinz, R. Waldner, K. Kolaric, R. Beuhner, W. Ten BokkelHuywinck, N.I. Perevodchikova, L.A. Manziuk, H.J. Senn, and A.C. Mayr, Cancer Treat. Rep. 63: 827 (1979).

    PubMed  CAS  Google Scholar 

  10. A. Trouet, D. Deprez-De Campeneere, and C. De Duve, Nature New Biol. 238: 110 (1972).

    Google Scholar 

  11. A. Trouet, D. Deprez-De Campeneere, M. De Smedt-Malengreaux, and G. Atassi, Eur. J. Cancer 10: 405 (1974).

    PubMed  CAS  Google Scholar 

  12. C. Deckers, F. Mace, L. Deckers-Pauuau, and A. Trouet, in: “Molecular Base of Malignancy,” George Thieme Publishers, Stuttgart 254 (1976).

    Google Scholar 

  13. A. Langslet, I. Oye, and S.O. Lie, Acta Pharmacol. Toxicol. 35: 379 (1974).

    Article  CAS  Google Scholar 

  14. C. Paul et al, Proc. from the 5th Meeting of the Int. Soc. of Haematology, European and African Division, 36 (1979).

    Google Scholar 

  15. G. Gahrton, M. Björkholm, G. Brenning, I. Christenson, L. Engstedt, S. Franzén, B. Gullbring, G. Holm, C. Högman, P. Hörnsten, S. Jameson, A. Killander, C. Simonsson-Lindemalm, D. Lockner, B. Lönnquist, H. Mellstedt, J. Palmblad, C. Paul, C. Pauli, C. Peterson, P. Reizenstein, B. Simonsson, K.-0. Skârberg, A.-M. Udén, and B. Wadman, Cancer Chemother. Pharmacol. 2: 73 (1979).

    CAS  Google Scholar 

  16. C. Paul, C. Peterson, G. Gahrton, and D. Lockner, Cancer Chemother. Pharmacol. 2: 49 (1979).

    CAS  Google Scholar 

  17. J. Quintart, Ph.D. Thesis, Universite Catholique de Louvain, Belgium (1977).

    Google Scholar 

  18. P. Tulkens, H. Beaufay, and A. Trouet, J. Cell Biol. 63: 383 (1974).

    Article  PubMed  CAS  Google Scholar 

  19. P. Tulkens and A. Trouet, Arch. int. Physiol. Biochem. 80: 623 (1972).

    Google Scholar 

  20. S. Eksborg, H. Ehrsson, B. Andersson, and M. Beran, J. Chromat. 153: 211 (1978).

    Article  CAS  Google Scholar 

  21. R. Hulhoven, G. Sokal, and C. Harvengt, Cancer Chemother. Pharmacol. 3: 243 (1979).

    CAS  Google Scholar 

  22. C. Paul, B. Lönnquist, G. Gahrton, and C. Peterson, Cancer, in press.

    Google Scholar 

  23. C. Peterson, G. Noël, A. Zerebergh, and A. Trouet, Cancer Chemother. Pharmacol. 2: 3 (1979).

    CAS  Google Scholar 

  24. D. Deprez-De Campeneere, R. Baurain, M. Huybrechts, and A. Trouet, Cancer Chemother. Pharmacol. 2: 25 (1979).

    Google Scholar 

  25. F. Leighton, B. Poole, H. Beaufay, P. Bandhuin, J.W. Coffey, S. Fowler, and C. de Duve, J. Cell Biol. 37: 482 (1968).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer Science+Business Media New York

About this chapter

Cite this chapter

Peterson, C., Paul, C., Gahrton, G. (1981). Anthracycline-DNA Complexes as Slow-Release Preparations in the Treatment of Acute Leukemia. In: Lewis, D.H. (eds) Controlled Release of Pesticides and Pharmaceuticals. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0737-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0737-3_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0739-7

  • Online ISBN: 978-1-4757-0737-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics